FORA Capital LLC lowered its stake in Xylem Inc. (NYSE:XYL - Free Report) by 71.4% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 8,566 shares of the industrial products company's stock after selling 21,335 shares during the period. FORA Capital LLC's holdings in Xylem were worth $1,023,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also made changes to their positions in XYL. Northern Trust Corp lifted its position in Xylem by 42.0% during the 4th quarter. Northern Trust Corp now owns 3,268,433 shares of the industrial products company's stock worth $379,204,000 after acquiring an additional 966,399 shares during the period. Lido Advisors LLC raised its stake in shares of Xylem by 15.7% in the fourth quarter. Lido Advisors LLC now owns 7,664 shares of the industrial products company's stock worth $889,000 after purchasing an additional 1,041 shares during the last quarter. Schonfeld Strategic Advisors LLC lifted its holdings in shares of Xylem by 30.0% during the fourth quarter. Schonfeld Strategic Advisors LLC now owns 3,499 shares of the industrial products company's stock worth $406,000 after purchasing an additional 808 shares during the period. Keel Point LLC boosted its position in Xylem by 4.1% in the fourth quarter. Keel Point LLC now owns 2,371 shares of the industrial products company's stock valued at $275,000 after buying an additional 93 shares during the last quarter. Finally, Mercer Global Advisors Inc. ADV increased its holdings in Xylem by 50.9% in the 4th quarter. Mercer Global Advisors Inc. ADV now owns 31,171 shares of the industrial products company's stock worth $3,616,000 after buying an additional 10,514 shares during the period. 87.96% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
XYL has been the subject of several research reports. TD Cowen lifted their price objective on shares of Xylem from $125.00 to $130.00 and gave the company a "hold" rating in a research note on Tuesday. Cowen restated a "hold" rating on shares of Xylem in a research report on Tuesday. JPMorgan Chase & Co. started coverage on Xylem in a research report on Friday, May 30th. They set an "overweight" rating and a $148.00 price target on the stock. Stifel Nicolaus lifted their price objective on Xylem from $162.00 to $175.00 and gave the company a "buy" rating in a research note on Friday, August 1st. Finally, UBS Group upped their target price on Xylem from $164.00 to $168.00 and gave the stock a "buy" rating in a research note on Tuesday, August 5th. Six investment analysts have rated the stock with a Buy rating and four have given a Hold rating to the company's stock. According to data from MarketBeat, Xylem presently has an average rating of "Moderate Buy" and a consensus target price of $152.29.
Read Our Latest Stock Report on XYL
Xylem Price Performance
Shares of NYSE XYL traded down $2.44 during trading on Friday, hitting $141.57. The company had a trading volume of 1,114,446 shares, compared to its average volume of 1,108,640. The stock has a fifty day simple moving average of $136.05 and a two-hundred day simple moving average of $126.87. Xylem Inc. has a fifty-two week low of $100.47 and a fifty-two week high of $145.33. The firm has a market capitalization of $34.46 billion, a price-to-earnings ratio of 30.91, a price-to-earnings-growth ratio of 2.45 and a beta of 1.11. The company has a quick ratio of 1.43, a current ratio of 1.90 and a debt-to-equity ratio of 0.17.
Xylem (NYSE:XYL - Get Free Report) last announced its earnings results on Thursday, July 31st. The industrial products company reported $1.26 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.15 by $0.11. Xylem had a net margin of 10.74% and a return on equity of 10.33%. The business had revenue of $2.30 billion for the quarter, compared to analyst estimates of $2.20 billion. During the same quarter last year, the business earned $1.09 earnings per share. The company's revenue for the quarter was up 6.1% compared to the same quarter last year. Xylem has set its FY 2025 guidance at 4.700-4.850 EPS. On average, research analysts expect that Xylem Inc. will post 4.65 earnings per share for the current year.
Xylem Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Thursday, September 25th. Stockholders of record on Thursday, August 28th will be given a $0.40 dividend. The ex-dividend date is Thursday, August 28th. This represents a $1.60 annualized dividend and a dividend yield of 1.1%. Xylem's dividend payout ratio (DPR) is 41.56%.
Xylem Profile
(
Free Report)
Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.
Featured Stories

Before you consider Xylem, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xylem wasn't on the list.
While Xylem currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.